I D
× COMMENTARYIN THE NEWSNEWSFRONTSCHEMENTATOR + Show More
Chemical EngineeringChementator briefs
Mercury removal Scientists at Flinders University (Adelaide, Australia; www.flinders.edu.au) have…
BUSINESS NEWSTECHNICAL & PRACTICALTOWER DOCTORFEATURE REPORTFACTS AT YOUR FINGERTIPSENGINEERING PRACTICEYOU AND YOUR JOBEQUIPMENT & SERVICESFOCUS
Weighing and Dosing
Pressure compensation ups accuracy in LIW feeders Loss-in-weight (LIW) feeder…
NEW PRODUCTS + Show More

Comment

Asahi Glass acquires German biopharmaceutical company Biomeva

By Mary Page Bailey |

Asahi Glass (AGC; Tokyo; www.agc.com) announces that it has acquired all of the shares  of Biomeva GmbH (Biomeva) from Biomeva Holding GmbH. Biomeva is one of the leading biopharmaceutical contract manufacturing organizations (CMO) in Europe. With Biomeva now a part of the AGC Group, AGC’s Life Science Business will be offering wider geographic coverage and a wider range of capacities.


Based in the Bio Cluster City of Heidelberg, Germany, Biomeva has almost 25 years of experience in providing contract development and manufacturing services using microbial expression technology to European and other International customers. Biomeva’s services include process development for highly efficient therapeutic protein expression, cGMP compliant fermentation, purification and bulk filling, as well as analytical testing and cell banking.


Dr. Thomas Pultar, CEO of Biomeva says “By combining Biomeva’s capabilities and AGC’s large scale manufacturing capacities we will generate a new and strong international microbial CMO, offering the complete services from process development to large scale market supply. To me, this is a perfect synergy between Biomeva’s strength in clinical manufacturing and AGC’s expertise and capacity for commercial production. I look forward to continuing my role as CEO of Biomeva under this new ownership.”


Under the management policy AGC plus, the AGC Group has designated Life Science Business as one of its strategic areas. The synergy generated through the business integration of AGC and Biomeva being an important addition, the AGC Group is dedicated to speeding up and expanding its biopharmaceutical contract services business.

Related Content

Chemical Engineering publishes FREE eletters that bring our original content to our readers in an easily accessible email format about once a week.
Subscribe Now
GMP In The Cosmetic Industry
Solve turbomachinery problems: Miba Tilting Pad Bearings
Six Steps to Designing a Storage Vessel That Really Works
SICK Solutions for Cleaner Industries - Powerful Transitions
Gain a Digital Line of Sight Across the Whole Lifecycle of the Plant with a Digital Twin

View More